Granite Bay Wealth Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.7M Sell
21,900
-721
-3% -$257K 1.64% 24
2025
Q4
$7.4M Sell
22,621
-658
-3% -$209K 1.78% 22
2025
Q3
$6.57M Buy
23,279
+2,568
+12% +$745K 1.71% 25
2025
Q2
$5.78M Buy
20,711
+2,879
+16% +$816K 1.86% 21
2025
Q1
$5.56M Buy
17,832
+1,763
+11% +$521K 1.93% 19
2024
Q4
$4.19M Buy
16,069
+1,005
+7% +$298K 1.55% 23
2024
Q3
$4.85M Buy
+15,064
New +$4.93M 2.72% 14
2024
Q2
Sell
-8,260
Closed -$2.35M 68
2024
Q1
$2.35M Sell
8,260
-6,230
-43% -$1.82M 1.34% 23
2023
Q4
$3.95M Hold
14,490
0.04% 124
2023
Q3
$3.62M Buy
+14,490
New +$3.62M 0.04% 134

Other funds holding AMGN

Granite Bay Wealth Management's AMGN Position: Q1 2026 in Review

Granite Bay Wealth Management reduced its Amgen (AMGN) stake by 3.2% in Q1 2026, selling an estimated $257K and leaving 21,900 shares worth $7.7M. The position accounts for 1.64% of the portfolio, ranked #24.

Granite Bay Wealth Management first reported a position in AMGN in Q3 2023 and has held it in 10 quarters since. 3,128 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Granite Bay Wealth Management held 21,900 shares of Amgen worth $7.7M as of Q1 2026.
  • Granite Bay Wealth Management sold 721 Amgen shares in Q1 2026, an estimated $257K.
  • Amgen made up 1.64% of Granite Bay Wealth Management's portfolio in Q1 2026, its #24 holding.
  • Granite Bay Wealth Management first reported a position in Amgen in Q3 2023 and has held it in 10 quarters since.
  • 3,128 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Granite Bay Wealth Management's 13F filing for Q1 2026, filed 1 May 2026.